GKOS
GKOS clinical trials: GLAUKOS Corp
Every trial on ClinicalTrials.gov where GLAUKOS Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 79
- Trials linked
- 67
- As lead sponsor
- 12
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
GKOS on the catalyst calendar · GKOS registry changes
- Primary completion Mar 2027Sponsor estimateNo phase registeredNCT07816692iDose TR Administration in an Office-Based Surgery SettingGlaukos Corporation · Open Angle Glaucoma (OAG)RecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2028Sponsor estimatePhase 2NCT07075718Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantGlaukos Corporation · GlaucomaRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2027Sponsor estimatePhase 4NCT07629557Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for KeratoconusGlaukos Corporation · KeratoconusRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2027Sponsor estimatePhase 4NCT06066645Travoprost Intraocular Implant + iStent InfiniteGlaukos Corporation · Glaucoma, Open-AngleRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2028Sponsor estimatePhase 3NCT07495852Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantGlaukos Corporation · GlaucomaRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2026Sponsor estimatePhase 2NCT07400965Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisGlaukos Corporation · Demodex BlepharitisRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2026Sponsor estimateNo phase registeredNCT07400926Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcgGlaukos Corporation · Open Angle Glaucoma (OAG)RecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimatePhase 2NCT07400952Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With KeratoconusGlaukos Corporation · KeratoconusRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2026Sponsor estimatePhase 4NCT06848946Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneGlaukos Corporation · Glaucoma, Open-angleRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2025Sponsor estimatePhase 2NCT05966493A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDGlaukos Corporation · Persistent Corneal Epithelial DefectRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 7, 2022ActualPhase 2NCT04081103NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular InjuriesGlaukos Corporation · Corneal Persistent Epithelial DefectTerminatedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 10, 2022ActualPhase 3NCT03868124Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantGlaukos Corporation · Glaucoma, Open-AngleCompletedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 5, 2022ActualPhase 3NCT03519386Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%Glaukos Corporation · Glaucoma, Open-AngleCompletedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2, 2023ActualPhase 2NCT06582732Performance of the Travoprost Intraocular ImplantGlaukos Corporation · Glaucoma, Open-AngleCompletedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 29, 2024ActualNo phase registeredNCT05127551Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. CompetitorGlaukos Corporation · GlaucomaUnknown statusGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2025Sponsor estimatePhase 1/Phase 2NCT05314738Safety and Efficacy of Corneal Cross-linking in Subjects With KeratoconusGlaukos Corporation · Progressive KeratoconusUnknown statusGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 18, 2024ActualPhase 3NCT06061718Travoprost Intraocular Implant in Conjunction With Cataract SurgeryGlaukos Corporation · Open Angle GlaucomaUnknown statusGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2026Sponsor estimateNo phase registeredNCT04624698iStent Inject New Enrollment Post-Approval StudyGlaukos Corporation · Glaucoma, Open-AngleUnknown statusGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2026Sponsor estimateNo phase registeredNCT03319082Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive SurgeryGlaukos Corporation · Corneal EctasiaUnknown statusGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 1, 2019ActualPhase 3NCT03442751Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive KeratoconusGlaukos Corporation · Progressive KeratoconusCompletedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2024Sponsor estimatePhase 2NCT06152861Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionGlaukos Corporation · Open Angle GlaucomaUnknown statusGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2025Sponsor estimateNo phase registeredNCT06057051Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle GlaucomaGlaukos Corporation · GlaucomaRecruitingGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 28, 2022ActualPhase 2NCT04615403Study of Exchange of Travoprost Intraocular ImplantGlaukos Corporation · Open Angle GlaucomaCompletedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2017ActualPhase 2NCT02754596Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic SolutionGlaukos Corporation · Glaucoma Open-angleCompletedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 6, 2022ActualPhase 2NCT05124275Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of PresbyopiaGlaukos Corporation · PresbyopiaCompletedGKOSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 54 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner